Is methylsulfonylmethane (MSM) safe to use with serotonin reuptake inhibitors (SRIs) and mirtazapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Methylsulfonylmethane (MSM) Safe with SRIs and Mirtazapine?

Yes, methylsulfonylmethane (MSM) appears safe to use with serotonin reuptake inhibitors (SRIs) and mirtazapine based on available evidence, as MSM has no documented serotonergic activity or cytochrome P450 interactions that would create safety concerns with these antidepressants.

Evidence for Safety

MSM Drug Interaction Profile

MSM has been specifically studied for drug interaction potential with cytochrome P450 enzymes. Research demonstrates that MSM shows no significant inhibitory effects on seven major CYP450 isoenzymes 1. This is clinically important because:

  • SRIs (SSRIs and SNRIs) are metabolized through various CYP450 pathways, particularly CYP2D6, CYP2C19, CYP3A4, and CYP1A2 2
  • Mirtazapine is also metabolized via CYP450 enzymes
  • MSM does not interfere with these metabolic pathways, making pharmacokinetic interactions unlikely

MSM Safety Profile

MSM is designated as Generally Recognized As Safe (GRAS) and is well-tolerated at doses up to 4 grams daily with few known and mild side effects 3. The supplement has been extensively studied in both animal models and human clinical trials without reports of serotonergic effects or interactions with antidepressants.

Key Serotonin Syndrome Considerations

While MSM appears safe, you must remain vigilant about serotonin syndrome when patients are on SRIs and mirtazapine, particularly when combining multiple serotonergic agents:

Recognized Serotonergic Substances to Avoid or Use Cautiously

The following substances DO carry serotonin syndrome risk when combined with SRIs/mirtazapine 2, 4:

  • MAOIs (contraindicated - including linezolid, isoniazid)
  • Other antidepressants (SSRIs, SNRIs, TCAs)
  • Opioids (tramadol, meperidine, methadone, fentanyl)
  • Triptans (migraine medications)
  • Over-the-counter products (St. John's Wort, L-tryptophan, dextromethorphan)
  • Stimulants (amphetamines, possibly methylphenidate)
  • Illicit drugs (MDMA/ecstasy, methamphetamine, cocaine, LSD)

MSM is notably absent from all guideline warnings about serotonin syndrome risk 2, 4.

Clinical Monitoring Recommendations

Despite MSM's apparent safety, when patients are on mirtazapine with or without SRIs, monitor for:

Serotonin Syndrome Signs (if adding ANY new serotonergic agent)

  • Mental status changes: confusion, agitation, anxiety
  • Neuromuscular symptoms: tremors, clonus, hyperreflexia, muscle rigidity
  • Autonomic instability: hypertension, tachycardia, diaphoresis, hyperthermia, vomiting, diarrhea
  • Advanced symptoms: fever, seizures, arrhythmias, unconsciousness 2, 4

Symptoms typically arise within 24-48 hours after combining serotonergic medications 2.

Mirtazapine-Specific Concerns (unrelated to MSM)

  • QTc prolongation - particularly with doses >45 mg or in patients with cardiovascular disease 4
  • Agranulocytosis - monitor for fever, sore throat, infections 4
  • Sedation and weight gain - common side effects 5, 6

Bottom Line

MSM does not appear on any guideline or drug label warnings for serotonin syndrome or drug interactions with antidepressants. The research specifically examining MSM's CYP450 interaction potential found no significant effects 1. This combination should be safe, but maintain standard monitoring for patients on antidepressants, particularly watching for signs of serotonin syndrome if ANY other serotonergic substances are added to the regimen.

The real concern with mirtazapine and SRIs is combining them with other serotonergic agents listed above, not with MSM supplementation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.